Cancer BiologybioRxivPreprint
Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion
c. gaiteiro, J. Soares, M. Relvas Santos…·J. A. Ferreira
This study identifies CD44s as a biomarker of poor prognosis in bladder cancer and demonstrates the utility of glycoproteogenomics for characterizing splicing and glycosylation patterns linked to cancer invasion.
DOI 10.1101/2021.09.04.458979